BeiGene's (BGNE) Shares Surge 32% in a Month: Here's Why [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
The company currently markets three internally discovered oncology products, including BTK inhibitor, Brukinsa (zanubrutinib), in the United States, China, the EU, the United Kingdom and additional international markets. BeiGene markets its other products like anti-PD-1 antibody, tislelizumab, in the EU and China, and PARP inhibitor, pamiparib, only in China. Together, these three marketed products, either as a monotherapy or in combination with other agents, treat a plethora of oncology indications across several geographies, including the United States, the EU, the UK and China. The company has also in-licensed the rights to distribute additional approved medicines for the China market, which contributes to its top line as well. In the past month, BeiGene's shares rallied 32%, which was mainly driven by the European Commission's approval of an application in April 2024, seeking the label expansion of tislelizumab as a treatment for adult patients with non-small cell lung canc
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Implied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Is Undervalued, As Royalty Potential Is Overlooked [Seeking Alpha]Seeking Alpha
- ANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare ConferenceGlobeNewswire
- SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP)PR Newswire
- Down -6.19% in 4 Weeks, Here's Why ANI (ANIP) Looks Ripe for a Turnaround [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 5/10/24 - Beat
ANIP
Sec Filings
- 6/14/24 - Form 4
- 6/11/24 - Form 4
- 6/6/24 - Form 4
- ANIP's page on the SEC website